IFNλ4 Gene Variants Are Associated with CD8+ T Cell IL-2 Response After COVID-19 Vaccination: A Preliminary Study
Biomolecules · 29.07.2026 · 16 (8) · 1111
DOI: 10.3390/biom16081111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 29.07.2026. Verfasst von Giuseppa Luisa Sanfilippo und 6 weiteren Autor:innen. Beteiligte Einrichtung: G. Giglio Institute Foundation, 90015 Cefalù, Italy. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Interleukin-2, Interleukins, COVID-19. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Palermo.
Abstract (Originalsprache)
Individual responses to SARS-CoV-2 vaccination vary due to viral mutations, demographic factors, and genetic background, with T-cell responses being less affected by viral variability. However, less is known about the effect of age, sex, and genetic background on the T-cell response in vaccinated subjects. In particular, the influence of interferon lambda (IFN-λ) genetic polymorphisms on vaccine-induced cellular immunity has been poorly explored. Here, we assessed intracellular production of IFNγ, TNFα, and IL-2 in CD4+ and CD8+ T cells stimulated with SARS-CoV-2 spike peptides from 50 vaccinated subjects genotyped for IFNL3 (rs12980275 and rs8099917) and IFNL4 (rs11322783TT and rs12979860) SNPs. We found that the IFNL4 rs11322783TT/TT genotype is associated with increased IL-2 production in CD8+ T cells, whereas the ΔG allele correlates with a reduced IL-2 response. No significant effects on CD4+ T-cell cytokine production or other cytokines were observed. These preliminary findings suggest that type III interferon gene variants might be involved in CD8+ T-cell responses post-vaccination, opening the possibility that evaluation of IFNL4 SNPs might be useful in designing strategies of personalized vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- G. Giglio Institute Foundation, 90015 Cefalù, Italy.
- Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), Azienda Ospedaliera Universitaria Policlinico (AOUP) Paolo Giaccone, University of Palermo, 90127 Palermo, Italy.
- Department of Biomedicine, Neurosciences and Advanced Diagnostic (Bi.N.D.), University of Palermo, 90127 Palermo, Italy.
- Microbiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
- IRCCS ISMETT, 90127 Palermo, Italy.
- University Research Center "Migrate", University of Palermo, 90133 Palermo, Italy.
ORCID-Profile: Giusto Davide Badami, Marco Pio La Manna, Domenico Lio, Giovanni Maurizio Giammanco, Nadia Caccamo
Förderung
- University of Palermo
Zitieren
APA
Sanfilippo, G. L., Badami, G. D., La Manna, M. P., Pizzo, M., Lio, D., Giammanco, G. M., & Caccamo, N. (2026). IFNλ4 Gene Variants Are Associated with CD8+ T Cell IL-2 Response After COVID-19 Vaccination: A Preliminary Study. Biomolecules, 16(8), 1111. https://doi.org/10.3390/biom16081111
Vancouver
Sanfilippo GL, Badami GD, La Manna MP, Pizzo M, Lio D, Giammanco GM, et al. IFNλ4 Gene Variants Are Associated with CD8+ T Cell IL-2 Response After COVID-19 Vaccination: A Preliminary Study. Biomolecules. 2026;16(8):1111. doi:10.3390/biom16081111
BibTeX
@article{Sanfilippo2026,
author = {Sanfilippo, Giuseppa Luisa and Badami, Giusto Davide and La Manna, Marco Pio and Pizzo, Mariangela and Lio, Domenico and Giammanco, Giovanni Maurizio and Caccamo, Nadia},
title = {IFNλ4 Gene Variants Are Associated with CD8+ T Cell IL-2 Response After COVID-19 Vaccination: A Preliminary Study},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1111},
doi = {10.3390/biom16081111}
}
EUVIMED